PLx Pharma Price Prediction

PLXPDelisted Stock  USD 0  0.00  0.00%   
As of today, the value of RSI of PLx Pharma's share price is approaching 40 indicating that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling PLx Pharma, making its price go up or down.

Oversold Vs Overbought

40

 
Oversold
 
Overbought
PLx Pharma stock price prediction is an act of determining the future value of PLx Pharma shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of PLx Pharma's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of PLx Pharma and does not consider all of the tangible or intangible factors available from PLx Pharma's fundamental data. We analyze noise-free headlines and recent hype associated with PLx Pharma, which may create opportunities for some arbitrage if properly timed.
It is a matter of debate whether delisted stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of PLx Pharma based on different types of headlines from major news networks to social media. The PLx stock price prediction module provides an analysis of price elasticity to changes in media outlook on PLx Pharma over a specific investment horizon. Using PLx Pharma hype-based prediction, you can estimate the value of PLx Pharma from the perspective of PLx Pharma response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in PLx Pharma. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in PLx Pharma to buy its stock at a price that has no basis in reality. In that case, they are not buying PLx because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

PLx Pharma after-hype prediction price

    
  USD 0.005  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of PLx Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.0000.00
Details
Naive
Forecast
LowNextHigh
0.020.020.02
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
000.01
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as PLx Pharma. Your research has to be compared to or analyzed against PLx Pharma's peers to derive any actionable benefits. When done correctly, PLx Pharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in PLx Pharma.

PLx Pharma After-Hype Price Prediction Density Analysis

As far as predicting the price of PLx Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in PLx Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of PLx Pharma, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

PLx Pharma Estimiated After-Hype Price Volatility

In the context of predicting PLx Pharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on PLx Pharma's historical news coverage. PLx Pharma's after-hype downside and upside margins for the prediction period are 0.00 and 0.01, respectively. We have considered PLx Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0
0.01
After-hype Price
0.01
Upside
PLx Pharma is very steady at this time. Analysis and calculation of next after-hype price of PLx Pharma is based on 3 months time horizon.

PLx Pharma Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as PLx Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading PLx Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with PLx Pharma, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.00  
0.00
 0.00  
 0.00  
3 Events / Month
11 Events / Month
In about 3 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0
0.01
25.00 
0.00  
Notes

PLx Pharma Hype Timeline

PLx Pharma is at this time traded for 0. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. PLx is anticipated to increase in value after the next headline, with the price projected to jump to 0.005 or above. The average volatility of media hype impact on the company the price is insignificant. The price gain on the next news is projected to be 25.0%, whereas the daily expected return is at this time at 0.0%. The volatility of related hype on PLx Pharma is about 0.0%, with the expected price after the next announcement by competition of 0.00. The company currently holds 202 K in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. PLx Pharma has a current ratio of 4.48, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist PLx Pharma until it has trouble settling it off, either with new capital or with free cash flow. So, PLx Pharma's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like PLx Pharma sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for PLx to invest in growth at high rates of return. When we think about PLx Pharma's use of debt, we should always consider it together with cash and equity.Given the investment horizon of 90 days the next anticipated press release will be in about 3 days.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.

PLx Pharma Related Hype Analysis

Having access to credible news sources related to PLx Pharma's direct competition is more important than ever and may enhance your ability to predict PLx Pharma's future price movements. Getting to know how PLx Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how PLx Pharma may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
BFRIBiofrontera 0.15 6 per month 9.90  0.04  24.68 (18.71) 74.86 
GHSIGuardion Health Sciences(0.58)4 per month 2.88  0.10  8.85 (7.60) 75.75 
SHPHShuttle Pharmaceuticals 0.00 6 per month 0.00 (0.05) 6.98 (5.00) 38.63 
AKANAkanda Corp 0.01 9 per month 0.00 (0.19) 16.13 (25.00) 51.67 
CPHIChina Pharma Holdings 0.01 6 per month 0.00 (0.09) 10.81 (9.09) 33.40 
CNNACann American Corp(0.12)14 per month 11.35  0.09  40.00 (16.67) 108.93 
ACORAcorda Therapeutics(0.01)6 per month 0.00 (0.26) 8.87 (19.64) 96.13 
KALAKala Pharmaceuticals(0.09)7 per month 0.00 (0.15) 4.50 (4.18) 23.79 
MNKMallinckrodt Plc(0.09)9 per month 0.00 (0.03) 32.12 (30.95) 219.70 
HCANFHalo Collective 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
ALIMAlimera Sciences 0.09 8 per month 0.00 (0.08) 4.66 (5.04) 16.30 
SXTCChina SXT Pharmaceuticals 0.03 5 per month 0.00 (0.06) 10.45 (12.61) 65.62 
PTPIPetros Pharmaceuticals(0.06)8 per month 0.00 (0.10) 10.00 (8.97) 49.94 
SCTLSocietal CDMO 0.01 6 per month 2.84  0.14  12.50 (5.71) 134.46 
ORGOOrganogenesis Holdings(0.17)8 per month 0.00 (0.10) 5.34 (5.44) 25.39 
LFCRLifecore Biomedical(0.04)7 per month 5.76  0.02  9.04 (4.88) 46.34 
OPTNOptiNose 0.02 6 per month 0.00 (0.12) 7.30 (8.40) 22.05 

PLx Pharma Additional Predictive Modules

Most predictive techniques to examine PLx price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for PLx using various technical indicators. When you analyze PLx charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About PLx Pharma Predictive Indicators

The successful prediction of PLx Pharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as PLx Pharma, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of PLx Pharma based on analysis of PLx Pharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to PLx Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to PLx Pharma's related companies.

Story Coverage note for PLx Pharma

The number of cover stories for PLx Pharma depends on current market conditions and PLx Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that PLx Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about PLx Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

PLx Pharma Short Properties

PLx Pharma's future price predictability will typically decrease when PLx Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of PLx Pharma often depends not only on the future outlook of the potential PLx Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. PLx Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding23.7 M
Cash And Short Term Investments69.4 M
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.
You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Consideration for investing in PLx Stock

If you are still planning to invest in PLx Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PLx Pharma's history and understand the potential risks before investing.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Transaction History
View history of all your transactions and understand their impact on performance
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine